Cambridge Heart to Host Third Quarter Conference Call.Business Editors and Health/Medical Writers BEDFORD, Mass.--(BW HealthWire)--Oct. 20, 2000 Cambridge Heart, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CAMH CAMH Centre for Addiction and Mental Health CAMH Contemporary Arts Museum Houston (Houston, TX) CAMH Comprehensive Accreditation Manual for Hospitals ) today announced that the Company will hold a conference call at 4:30 p.m. eastern time on Wednesday October 25, 2000 to discuss the financial results for the three and nine month periods ended September 30, 2000. Jeffrey M. Arnold, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. will lead the call.
Date Wednesday, October 25, 2000
Time 4:30 p.m. eastern time
Phone Numbers - U.S. 800-665-0430
Outside U.S. 913-981-5591
Webcast www.cambridgeheart.com
Mr. Arnold will provide an update regarding recent Company developments. Mr. David Chazanovitz, President and Chief Operation Officer of the Company will also be available for questions. A recording of the call will be available for 48 hours after its conclusion by dialing 888-203-1112 within the U.S. or 719-457-0820 outside the U.S. The reservation number is 774323. This playback will begin approximately two hours following the call. The Cambridge Heart Alternans Test alternans test Cardiology A noninvasive test for detecting T-wave alternans and identifying Pts at high risk for life-threatening cardiac arrhythmias and sudden cardiac death. measures extremely subtle beat-to-beat fluctuations in a person's heartbeat called T-wave alternans T-wave alternans Cardiology A subtle every-other-beat variation in T waves that is prognostic of Pts at high risk for life-threatening cardiac arrhythmias and sudden cardiac death. See Alternans test. . These tiny heartbeat variations - measured at one millionth of a volt - are detected during a typical treadmill or bicycle exercise stress test by proprietary sensors placed on a patient's chest. Extensive clinical research has shown that patients with symptoms of or at risk of life threatening arrhythmias who test positive for T-wave alternans are at significant risk for subsequent sudden cardiac events including sudden death. The Company, founded in 1992, is based in Bedford, Massachusetts Bedford is a town in Middlesex County, Massachusetts, United States. It is within the Greater Boston area, some 15 miles north-west of the city of Boston. The population of Bedford was 12,595 at the 2000 census. and is traded on the NASDAQ under the symbol CAMH. Cambridge Heart can be found on the World Wide Web at www.cambridgeheart.com. Statements made during this conference call that are not historical facts include forward-looking statements that involve risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements including uncertainties concerning market acceptance, reimbursement and other factors that are included in Cambridge Heart's Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. and other filings with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion